Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	21148
Country	United States

Received	2015-06-29 11:34
Peer-Review Started	2015-07-03 13:22
To Make the First Decision	2015-09-16 09:12
Return for Revision	2015-09-22 16:57
Revised	2015-10-16 02:21
Second Decision	2015-11-12 14:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-11-25 17:26
Articles in Press	2015-11-25 17:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-23 20:21
Publish the Manuscript Online	2016-01-31 19:20

ISSN	2218-6220 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Review
Article Title	Update on human papillomavirus vaccination: Where are we now?
Manuscript Source	Invited Manuscript
All Author List	Eloise Chapman-Davis, Lauren E Dockery, Kendall Griffith and Caroline Stroup
Funding Agency and Grant Number
Corresponding Author	Dr. Eloise Chapman-Davis, Department of Obstetrics and Gynecology, Division of Gynecologic Onco­logy, Tufts University School of Medicine, Tufts Medical Center, 800 Washington Street #232, Boston, MA 02111, United States. eloise.chapman@gmail.com
Key Words	Human papillomavirus; Vaccines; Cervical cancer; Cancer prevention; Public health
Core Tip	Human papilloma virus (HPV) represents the major cause of pre-invasive and invasive lesions of the urogenital tract. This article will review the efficacy, safety and approval of the currently available vaccines against HPV including the bivalent, quadrivalent and nine-valent vaccines. Indications for use in men, immu-nocompromised individuals and older cohorts will also be discussed. Additionally a summary of worldwide vaccination practices, cost effectiveness, vaccination and methods to improve vaccination uptake and acceptance will be reviewed.
Publish Date	2016-01-31 19:20
Citation	Chapman-Davis E, Dockery LE, Griffith K, Stroup C. Update on human papillomavirus vaccination: Where are we now? World J Obstet Gynecol 2016; 5(1): 5-15
URL	http://www.wjgnet.com/2218-6220/full/v5/i1/5.htm
DOI	http://dx.doi.org/10.5317/wjog.v5.i1.5

Full Article (PDF)	WJOG-5-5.pdf
Full Article (Word)	WJOG-5-5.doc
Manuscript File	21148-Review.doc
Answering Reviewers	21148-Answering reviewers.pdf
Audio Core Tip	21148-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	21148-Conflict-of-interest statement.pdf
Copyright License Agreement	21148-Copyright assignment.pdf
Peer-review Report	21148-Peer-review(s).pdf
Scientific Misconduct Check	21148-Scientific misconduct check.pdf
Scientific Editor Work List	21148-Scientific editor work list.pdf